U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C14H21NO3S
Molecular Weight 283.386
Optical Activity ( - )
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of REPARIXIN

SMILES

CC(C)CC1=CC=C(C=C1)[C@@H](C)C(=O)NS(C)(=O)=O

InChI

InChIKey=KQDRVXQXKZXMHP-LLVKDONJSA-N
InChI=1S/C14H21NO3S/c1-10(2)9-12-5-7-13(8-6-12)11(3)14(16)15-19(4,17)18/h5-8,10-11H,9H2,1-4H3,(H,15,16)/t11-/m1/s1

HIDE SMILES / InChI

Molecular Formula C14H21NO3S
Molecular Weight 283.386
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 15:59:19 UTC 2023
Edited
by admin
on Sat Dec 16 15:59:19 UTC 2023
Record UNII
U604E1NB3K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
REPARIXIN
INN   MART.   USAN  
INN   USAN  
Official Name English
DF 1681Y
Code English
Reparixin [WHO-DD]
Common Name English
REPARIXIN [USAN]
Common Name English
REPARIXIN [MART.]
Common Name English
BENZENEACETAMIDE, .ALPHA.-METHYL-4-(2-METHYLPROPYL)-N-(METHYLSULFONYL)-, (.ALPHA.R)-
Systematic Name English
REPERTAXIN
Common Name English
reparixin [INN]
Common Name English
DF-1681Y
Code English
DF1681Y
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 373312
Created by admin on Sat Dec 16 15:59:19 UTC 2023 , Edited by admin on Sat Dec 16 15:59:19 UTC 2023
NCI_THESAURUS C63817
Created by admin on Sat Dec 16 15:59:19 UTC 2023 , Edited by admin on Sat Dec 16 15:59:19 UTC 2023
EU-Orphan Drug EU/3/11/912
Created by admin on Sat Dec 16 15:59:19 UTC 2023 , Edited by admin on Sat Dec 16 15:59:19 UTC 2023
FDA ORPHAN DRUG 162802
Created by admin on Sat Dec 16 15:59:19 UTC 2023 , Edited by admin on Sat Dec 16 15:59:19 UTC 2023
Code System Code Type Description
PUBCHEM
9838712
Created by admin on Sat Dec 16 15:59:19 UTC 2023 , Edited by admin on Sat Dec 16 15:59:19 UTC 2023
PRIMARY
CAS
266359-83-5
Created by admin on Sat Dec 16 15:59:19 UTC 2023 , Edited by admin on Sat Dec 16 15:59:19 UTC 2023
PRIMARY
USAN
RR-70
Created by admin on Sat Dec 16 15:59:19 UTC 2023 , Edited by admin on Sat Dec 16 15:59:19 UTC 2023
PRIMARY
EVMPD
SUB130481
Created by admin on Sat Dec 16 15:59:19 UTC 2023 , Edited by admin on Sat Dec 16 15:59:19 UTC 2023
PRIMARY
EPA CompTox
DTXSID6046509
Created by admin on Sat Dec 16 15:59:19 UTC 2023 , Edited by admin on Sat Dec 16 15:59:19 UTC 2023
PRIMARY
FDA UNII
U604E1NB3K
Created by admin on Sat Dec 16 15:59:19 UTC 2023 , Edited by admin on Sat Dec 16 15:59:19 UTC 2023
PRIMARY
DRUG BANK
DB12614
Created by admin on Sat Dec 16 15:59:19 UTC 2023 , Edited by admin on Sat Dec 16 15:59:19 UTC 2023
PRIMARY
ChEMBL
CHEMBL191413
Created by admin on Sat Dec 16 15:59:19 UTC 2023 , Edited by admin on Sat Dec 16 15:59:19 UTC 2023
PRIMARY
MESH
C490707
Created by admin on Sat Dec 16 15:59:19 UTC 2023 , Edited by admin on Sat Dec 16 15:59:19 UTC 2023
PRIMARY
SMS_ID
100000156558
Created by admin on Sat Dec 16 15:59:19 UTC 2023 , Edited by admin on Sat Dec 16 15:59:19 UTC 2023
PRIMARY
NCI_THESAURUS
C66515
Created by admin on Sat Dec 16 15:59:19 UTC 2023 , Edited by admin on Sat Dec 16 15:59:19 UTC 2023
PRIMARY
INN
8224
Created by admin on Sat Dec 16 15:59:19 UTC 2023 , Edited by admin on Sat Dec 16 15:59:19 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
NONCOMPETIVE BLOCKER OF THE ACTIVATION OF CXCR1 BY IL-8. DOES NOT BLOCK BINDING. PMN MIGRATION ASSAY.
ALLOSTERIC INHIBITOR
IC50
TARGET -> INHIBITOR
NONCOMPETIVE
ALLOSTERIC INHIBITOR
IC50
Related Record Type Details
ACTIVE MOIETY